MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0072703
Naman Global Impex Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹10.14 Cr
▼ 49% YoY
Net profit · FY 2024
₹34.3 Lakh
Net margin 3.4%
EBITDA · FY 2024
₹1.69 Cr
EBITDA margin 16.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹17.8 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Naman Global Impex Private Limited
Data last updated:
Naman Global Impex Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2014PTC254968. Its GSTIN is 27AAECN6455H1Z8 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nirmal Mohanlal Sakaria and Girish Mohanlal Sakaria.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.14 Cr, a decline of 49% compared to the previous year. For the same year it recorded a net profit of ₹34.3 Lakh (net margin 3.4%) and EBITDA of ₹1.69 Cr (EBITDA margin 16.7%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 11% over five years.
The company is associated with 1 brand: Naman Global Impex. As per MCA filings, the company has open charges of ₹17.8 Cr on record. Court records list 7 cases involving the company, including 7 filed by the company; 6 cases are pending.
Naman Global Impex Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0072703). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website namanglobalimpex.com.
Company details
CIN U24110MH2014PTC254968
Registration Number 254968
Incorporation Date 25 March 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0072703
Recognitions & Rankings of Naman Global Impex
Contact details
Naman Global Impex Private Limited's registered office is in Mumbai, Maharashtra. Its website is namanglobalimpex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 3 & 4 Ground Floor Plot – 13 Balaram Chamber Barrack Road New Marine, Lines, Mumbai, Maharashtra, India – 400020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Naman Global Impex Private Limited, buy the company report.
Comprehensive company report
Naman Global Impex Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Naman Global Impex operates one associated brand: Naman Global Impex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplies and exports generic, branded, and specialty medicines globally. | namanglobalimpex.com |
Business activity
The main business activity of Naman Global Impex is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Naman Global Impex Private Limited, buy the company report.
Financials of Naman Global Impex Private Limited
FY 2024 filings availableNaman Global Impex Private Limited reported revenue of ₹10.14 Cr (down 49% YoY) for FY 2024.
Revenue · FY 2024
₹10.14 Cr ▼ 49%
Net profit · FY 2024
₹34.3 Lakh margin 3.4%
EBITDA · FY 2024
₹1.69 Cr margin 16.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 21%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 12%
5 years · compounded
▲ 6%
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 49% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.69 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.7% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Naman Global Impex Private Limited, buy the company report.
Board of directors of Naman Global Impex Private Limited
Naman Global Impex has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Mohanlal Sakaria Also directs: Naman Globe Expo LLP, Naman Realty Impex LLP, Matoshree Health Care Private Limited and 1 more | Director | 25 Mar 2014 | 12 Years 7 Months | Current |
| Girish Mohanlal Sakaria | Director | 12 Mar 2024 | 2 Years 7 Months | Current |
Peer comparison
Naman Global Impex Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fidelity Life Sciences Private Limited | ₹10.18 Cr (FY 2025) | 5.0% | Pune, Maharashtra, India | |||
| Farmakal Health Care Private Limited | ₹10.17 Cr (FY 2025) | 14.0% | Indore, Madhya Pradesh, India | |||
| Cygnet Medical Private Limited | ₹10.16 Cr (FY 2024) | -12.0% | Mumbai, Maharashtra, India | |||
| Biomirra Biogenics Private Limited | ₹10.14 Cr (FY 2024) | 20.0% | Kozhikode, Kerala, India | |||
| Naman Global Impex Private Limitedthis company | ₹10.14 Cr (FY 2024) | ₹34.3 Lakh | 3.4% | -49.0% | Mumbai, Maharashtra, India | |
| Esscubes Medisiences Private Limited | ₹10.12 Cr (FY 2024) | -15.0% | Bangalore, Karnataka, India | |||
| NDC Drug and Chemical Company Private Limited | ₹10.08 Cr (FY 2025) | -25.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Naman Global Impex Private Limited, buy the company report.
Auditor
Naman Global Impex Private Limited is audited by Kamlesh Kumar Suthar for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kamlesh Kumar Suthar | FY 2023 | 600181 |
Shareholding
The shareholding of Naman Global Impex Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Naman Global Impex Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2021 | 100483017 | Yes Bank Limited | ₹17.8 Cr | Open |
To see the full charge records of Naman Global Impex Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Naman Global Impex Private Limited has 7 court cases on record: 7 filed by Naman Global Impex. 6 cases are pending and 1 is disposed.
Total cases
7
Filed by the company
7
Pending
6
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 3 | 0 | 3 |
| District courts | 2 | 0 | 1 |
| NCLT | 2 | 0 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Chairperson Court | Tribunal matter | Filed by the company against Rathod Pharmachem Pvt Ltd | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Rathod Pharmachem Pvt Ltd and 1 other | Pending |
| NCLT, Ahmedabad | Insolvency matter | Filed by the company against Rathod Pharmachem Pvt Ltd and 1 other | Pending |
| NCLT, Ahmedabad | Insolvency matter | Filed by the company against Rathod Pharmachem Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against individuals | Pending |
To see the full case history of Naman Global Impex Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Naman Global Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Naman Global Impex has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN6455H1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Naman Global Impex Private Limited, buy the company report.
Recent activity
Naman Global Impex Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Girish Mohanlal Sakaria was appointed as Director on 12 Mar 2024.
AGM
Naman Global Impex Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Naman Global Impex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Appointed
Girish Mohanlal Sakaria was appointed as Director.
Ceased
Sanjaykumar Mohanlal Sakaria ceased to be Director.
Charges
A charge with Yes Bank Limited of Rs. 1,780.00 Lakh registered on 18 Sep 2021 with Charge ID 100483017 was modified on 23 Feb 2022.
Charges
A charge with Yes Bank Limited amounted to Rs. 1,780.00 Lakh with Charge ID 100483017 was registered on 18 Sep 2021.
Ceased
Girish Mohanlal Sakaria ceased to be Director.
Ceased
Pinesh Mohanlal Sakaria ceased to be Director.
Appointed
Nirmal Mohanlal Sakaria was appointed as Director.
Incorporation
25 Mar 2014
Naman Global Impex Private Limited was registered on 25 Mar 2014 with Roc Mumbai I & aged 12 years 7 months as per MCA records.
Frequently asked questions
Naman Global Impex is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2014 (12+ years old) and is registered under CIN U24110MH2014PTC254968.
Naman Global Impex has 2 current directors:
- Nirmal Mohanlal Sakaria - Director
- Girish Mohanlal Sakaria - Director
The latest financial statements of Naman Global Impex on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Naman Global Impex is 27AAECN6455H1Z8, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Naman Global Impex is U24110MH2014PTC254968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Naman Global Impex has 7 court cases on record: 7 filed by the company. 6 are pending. Most are in the nclat.
Naman Global Impex was incorporated on 25 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Naman Global Impex by revenue are Fidelity Life Sciences Private Limited, Farmakal Health Care Private Limited, Cygnet Medical Private Limited, Biomirra Biogenics Private Limited, Esscubes Medisiences Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Girish Mohanlal Sakaria was appointed as Director on 12 Mar 2024. Sanjaykumar Mohanlal Sakaria ceased to be Director on 12 Mar 2024. Girish Mohanlal Sakaria ceased to be Director on 15 Mar 2018. Naman Global Impex has 5 board changes on record in total.
Yes, Naman Global Impex is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0072703).
Naman Global Impex can be reached through the website namanglobalimpex.com. Its registered office is in Mumbai, Maharashtra, India.